HK75195A - Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form - Google Patents

Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form

Info

Publication number
HK75195A
HK75195A HK75195A HK75195A HK75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A
Authority
HK
Hong Kong
Prior art keywords
plasmid
recovering
expression
active form
superoxide dismutase
Prior art date
Application number
HK75195A
Other languages
English (en)
Inventor
Jacob R Hartman
Yaffa Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of HK75195A publication Critical patent/HK75195A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK75195A 1985-11-22 1995-05-18 Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form HK75195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
HK75195A true HK75195A (en) 1995-05-26

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
HK75195A HK75195A (en) 1985-11-22 1995-05-18 Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form

Country Status (21)

Country Link
JP (2) JP2609449B2 (xx)
AT (1) AT400443B (xx)
AU (1) AU607897B2 (xx)
BE (1) BE905796A (xx)
CA (1) CA1341362C (xx)
CH (1) CH676990A5 (xx)
DE (1) DE3639725C2 (xx)
DK (1) DK534686A (xx)
ES (1) ES2003518A6 (xx)
FI (1) FI90353C (xx)
FR (1) FR2590591B1 (xx)
GB (1) GB2183658B (xx)
GR (1) GR862713B (xx)
HK (1) HK75195A (xx)
IE (1) IE59498B1 (xx)
IL (2) IL80702A0 (xx)
IT (1) IT1205418B (xx)
LU (1) LU86676A1 (xx)
NL (1) NL8602960A (xx)
PT (1) PT83792B (xx)
SE (1) SE8604884L (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
JP3013896B2 (ja) * 1987-03-27 2000-02-28 バイオ−テクノロジー・ジエネラル・コーポレイシヨン ヒトマンガンスーパーオキシドジスムターゼを含む薬剤組成物
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
ATE209928T1 (de) * 1992-09-09 2001-12-15 Bio Technology General Corp Verwendung von mangan-superoxiddismutase (mn-sod) zur herstellung von arzneimitteln zur behandlung von erkrankungen in niedriger dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0138111B1 (en) * 1983-10-03 1991-11-21 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms

Also Published As

Publication number Publication date
FI864756A (fi) 1987-05-23
FR2590591B1 (fr) 1989-12-01
PT83792B (pt) 1989-01-17
IL106449A0 (en) 1993-11-15
SE8604884L (sv) 1987-05-23
GB2183658B (en) 1990-04-25
PT83792A (en) 1986-12-01
IT8667865A0 (it) 1986-11-21
FI90353B (fi) 1993-10-15
DE3639725A1 (de) 1987-07-23
ATA308986A (de) 1995-05-15
NL8602960A (nl) 1987-06-16
DK534686D0 (da) 1986-11-07
SE8604884D0 (sv) 1986-11-14
IL80702A0 (en) 1987-02-27
LU86676A1 (fr) 1987-05-04
GB2183658A (en) 1987-06-10
IL106449A (en) 1997-02-18
GR862713B (en) 1987-03-24
GB8627294D0 (en) 1986-12-17
FR2590591A1 (fr) 1987-05-29
ES2003518A6 (es) 1988-11-01
FI864756A0 (fi) 1986-11-21
CA1341362C (en) 2002-05-28
IE862851L (en) 1987-05-22
FI90353C (fi) 1994-01-25
DE3639725C2 (de) 1998-02-19
IT1205418B (it) 1989-03-15
CH676990A5 (xx) 1991-03-28
AU607897B2 (en) 1991-03-21
JPS62289187A (ja) 1987-12-16
JP2609449B2 (ja) 1997-05-14
BE905796A (fr) 1987-03-16
AT400443B (de) 1995-12-27
AU6497586A (en) 1987-05-28
DK534686A (da) 1987-05-23
JPH08289792A (ja) 1996-11-05
JP2967557B2 (ja) 1999-10-25
IE59498B1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
HK75195A (en) Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
EP0190736A3 (en) Chemical derivatives of ghl-cu
PH24833A (en) Ascorbic acid derivatives and pharmaceutical composition thereof
NZ223227A (en) Phosphinothricin-resistance gene active in plants and its use
NZ216419A (en) An organosilane-treated membrane and its use in an enzyme electrode
CS938286A2 (en) Fungicide and method of active substances production
DE3664119D1 (en) Castor wheel and method of manufacture
AU6351186A (en) Pharmaceutical composition comprising 1-hydroxy-2-pyridone and method for the treatment of acne
GB8719191D0 (en) Improvements in and relating to target track assessment
AU6219186A (en) Expression of a polypeptide having the enzymatic activity of naturally-occurring human CU-ZN superoxide dismutase in mammalian cells
DE3661878D1 (en) Tobacco composition containing apocynum venetum or an extract thereof, and process to prepare it
DE3665853D1 (en) Active carbon and process for its manufacture
ZA868610B (en) Human manganese superoxide dismutase cdna,its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase
IL85905A0 (en) Immunogenic recombinant yeast expression product and method for purifying it
IL80587A0 (en) Alpha-(aminoalkyl)-arylacetic acid derivatives and their preparation
PT79810B (en) Expression of human alpha-1-antitrysin in yeast
IL120245A0 (en) Enzymatically active analogs and mutants of human manganese superoxide dismutase
GB2172704B (en) Antigenically active protein and its use in the diagnosis of gonorrhoea
AU1763188A (en) Recovery of proteins in active form
AU4864885A (en) Medicinal composition and method of treatment of periarthritis and similar diseases
IE881466L (en) Ascorbic acid intermediates and process enzymes
AU5012185A (en) Ascorbic acid derivatives and processes
GB2192402B (en) Stabilization of xanthan gum in aqueous solution
BG40884A1 (en) Method for treatment of isolated cells for morphologic investigations and capsule for its implementing
BG42200A1 (en) Cosmetic aerosol preparation for face and body

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)